GlassScriptPhysician profile
Britany Epstein
NPI 1689018251
$11,816.84
in general payments reported to CMS, 2019-2025
42 companies · $2,291 in 2025
The $2,291 reported for 2025 was more than what 79% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $808 · 2020: $887 · 2021: $1,825 · 2022: $2,592 · 2023: $1,656 · 2024: $1,758 · 2025: $2,291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,705 · Education: $0.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,704.94 |
| Education | $0.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,330.33 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,249.77 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Amgen INC. | $1,054.30 | 2019-2025 | Tepezza, Evenity, Repatha |
| Mannkind Corporation | $935.70 | 2019-2025 | Afrezza |
| Xeris Pharmaceuticals, INC. | $774.77 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Insulet Corporation | $764.69 | 2019-2025 | Omnipod |
| Sanofi-Aventis U.S. LLC | $735.58 | 2020-2025 | |
| Abbott Laboratories | $674.24 | 2022-2025 | Freestyle Libre 3 |
| Amneal Pharmaceuticals LLC | $326.35 | 2020-2025 | Unithroid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $289.18 | 2019-2025 | Jardiance |
| Corcept Therapeutics | $281.15 | 2019-2025 | Korlym |
| Dexcom, INC. | $254.50 | 2021-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $234.95 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $187.65 | 2019-2023 | Farxiga |
| Tandem Diabetes Care, INC. | $172.30 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $166.27 | 2020-2023 | |
| Horizon Therapeutics Plc | $164.25 | 2022-2023 | Tepezza |
| Boston Scientific Corporation | $125.00 | 2019 | |
| Zealand Pharma US, INC. | $119.55 | 2020-2021 | |
| Amarin Pharma, INC. | $96.45 | 2019-2022 | |
| Antares Pharma, INC. | $89.18 | 2021-2023 | Tlando, Nocdurna, Xyosted |
| Ibsa Pharma INC. | $85.73 | 2022-2025 | Tirosint, Licart, Flector |
| Madrigal Pharmaceuticals | $81.54 | 2025 | Rezdiffra |
| Cequr Corporation | $81.20 | 2023-2025 | Cequr Simplicity |
| Averitas Pharma INC. | $78.91 | 2024-2025 | Qutenza |
| Alexion Pharmaceuticals, INC. | $58.77 | 2022-2025 | Strensiq |
| Kyowa Kirin, INC. | $52.81 | 2023-2025 | Crysvita |
| Recordati_rare_diseases_inc. | $42.17 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.14 | 2022-2023 | Cycloset |
| Tolmar, INC. | $33.68 | 2025 | Jatenzo |
| Ascendis Pharma Endocrinology INC | $33.61 | 2025 | Yorvipath |
| Intuitive Surgical, INC. | $25.20 | 2019 | |
| Embecta Corp. | $24.07 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Becton, Dickinson and Company | $21.76 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $21.57 | 2023 | Somatuline Depot |
| Pfizer INC. | $19.41 | 2025 | |
| Eisai INC. | $17.57 | 2025 | |
| Beta Bionics, INC. | $16.53 | 2024 | Ilet Bionic Pancreas |
| Medtronic, INC. | $15.30 | 2021 | |
| Organogenesis INC. | $14.66 | 2019 | |
| Rgh Enterprises LLC | $13.89 | 2025 | |
| Medtronic Minimed, INC. | $11.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Britany Epstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.